RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Hyloris Pharmaceuticals Stock

Hyloris Pharmaceuticals P/S 2024

Hyloris Pharmaceuticals P/S

38.31

Ticker

HYL.BR

ISIN

BE0974363955

WKN

A2P7Y0

As of Nov 5, 2024, Hyloris Pharmaceuticals's P/S ratio stood at 38.31, a -75.28% change from the 154.96 P/S ratio recorded in the previous year.

The Hyloris Pharmaceuticals P/S history

Hyloris Pharmaceuticals Aktienanalyse

What does Hyloris Pharmaceuticals do?

Hyloris Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Hyloris Pharmaceuticals's P/S Ratio

Hyloris Pharmaceuticals's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Hyloris Pharmaceuticals's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Hyloris Pharmaceuticals's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Hyloris Pharmaceuticals’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Hyloris Pharmaceuticals stock

What is the price-to-earnings ratio of Hyloris Pharmaceuticals?

The price-earnings ratio of Hyloris Pharmaceuticals is currently 38.31.

How has the price-earnings ratio of Hyloris Pharmaceuticals changed compared to last year?

The price-to-earnings ratio of Hyloris Pharmaceuticals has increased by -75.28% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Hyloris Pharmaceuticals high compared to other companies?

Yes, the price-to-earnings ratio of Hyloris Pharmaceuticals is high compared to other companies.

How does an increase in the price-earnings ratio of Hyloris Pharmaceuticals affect the company?

An increase in the price-earnings ratio of Hyloris Pharmaceuticals would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Hyloris Pharmaceuticals affect the company?

A decrease in the price-earnings ratio of Hyloris Pharmaceuticals would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Hyloris Pharmaceuticals?

Some factors that influence the price-earnings ratio of Hyloris Pharmaceuticals are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Hyloris Pharmaceuticals pay?

Over the past 12 months, Hyloris Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Hyloris Pharmaceuticals is expected to pay a dividend of 0 EUR.

What is the dividend yield of Hyloris Pharmaceuticals?

The current dividend yield of Hyloris Pharmaceuticals is .

When does Hyloris Pharmaceuticals pay dividends?

Hyloris Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Hyloris Pharmaceuticals?

Hyloris Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Hyloris Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Hyloris Pharmaceuticals located?

Hyloris Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hyloris Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hyloris Pharmaceuticals from 11/5/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 11/5/2024.

When did Hyloris Pharmaceuticals pay the last dividend?

The last dividend was paid out on 11/5/2024.

What was the dividend of Hyloris Pharmaceuticals in the year 2023?

In the year 2023, Hyloris Pharmaceuticals distributed 0 EUR as dividends.

In which currency does Hyloris Pharmaceuticals pay out the dividend?

The dividends of Hyloris Pharmaceuticals are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Hyloris Pharmaceuticals

Our stock analysis for Hyloris Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hyloris Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.